gip and glp 1 receptor agonist Dual GIP/GLP-1 agonists: New advances for treating type-2 diabetes LY3437943, a novel triple glucagon,

If you and your doctor determine that Saxenda is safe and effective for you, youll likely use it long term

However, this evidence is limited, inconsistent, and does not demonstrate clinically significant effects comparable to prescription GLP-1 agonists

doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

Swallow it whole with a small sip of plain water (no more than 120ml)

[DOI] [PMC free article] [PubMed] [Google Scholar] 49.Prado C.M., Phillips S.M., Gonzalez M.C., Heymsfield S.B